Danaher Corporation (DHR)
| Market Cap | 215.16B |
| Revenue (ttm) | 26.72B |
| Net Income (ttm) | 5.45B |
| Shares Out | 714.50M |
| EPS (ttm) | 7.52 |
| PE Ratio | 40.09 |
| Forward PE | 30.86 |
| Dividend | $0.78 (0.26%) |
| Ex-Dividend Date | Sep 29, 2021 |
| Volume | 2,958,017 |
| Open | 301.13 |
| Previous Close | 300.43 |
| Day's Range | 300.33 - 302.66 |
| 52-Week Range | 210.71 - 333.73 |
| Beta | 0.72 |
| Analysts | Buy |
| Price Target | 332.29 (+10.3%) |
| Est. Earnings Date | Oct 21, 2021 |
About DHR
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to t...
Financial Performance
In 2020, Danaher's revenue was $22.28 billion, an increase of 24.42% compared to the previous year's $17.91 billion. Earnings were $3.65 billion, an increase of 21.21%.
Financial StatementsAnalyst Forecast
According to 21 analysts, the average rating for Danaher stock is "Buy." The 12-month stock price forecast is 332.29, which is an increase of 10.26% from the latest price.
News
Danaher (DHR) Earnings Expected to Grow: Should You Buy?
Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Danaher Releases 2021 Sustainability Report; Building A Strong Foundation Of Sustainability
WASHINGTON, Oct. 12, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company"), the global science and technology innovator, today released its 2021 Sustainability Report and highlighted the ...
Why Danaher (DHR) Could Beat Earnings Estimates Again
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Danaher Corp (DHR) Sees Hammer Chart Pattern: Time to Buy?
Danaher Corp (DHR) has been struggling lately, but the selling pressure may be coming to an end soon.
3 Reasons Growth Investors Will Love Danaher (DHR)
Danaher (DHR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Looking for Earnings Suprise? Play These 5 Stocks
Bet big on the concept positive earnings surprise rather than earnings growth through these 5 stocks.
Down 6.2% in 4 Weeks, Here's Why Danaher (DHR) Looks Ripe for a Turnaround
Danaher (DHR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earn...
Here's How Much $100 Invested In Danaher 15 Years Ago Would Be Worth Today
Danaher (NYSE:DHR) has outperformed the market over the past 90 days by 10.15%, generating a 10.28% return for its investors over the time period. Now, given this information, it may seem like price app...
Beckman Coulter's new urinalysis solution improves laboratory workflow by significantly reducing manual reviews to 4%...
ATLANTA, Sept. 28, 2021 /PRNewswire/ -- Beckman Coulter today announced the launch of its DxU Iris Workcell at the AACC Annual Scientific Meeting & Clinical Lab Expo.
Fed Gives Bond-Buy Tapering Signal Without Timeline: 5 Picks
We have narrowed down our search to five U.S. corporate behemoths that have strong growth potential for the rest of 2021. These are: AAPL, MSFT, NVDA, DHR and COST.
Danaher Schedules Third Quarter 2021 Earnings Conference Call
WASHINGTON, Sept. 21, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2021 on Thursday, October 21, 2021 ...
Forget Earnings Growth, Focus on Beat With These 5 Stocks
Inside the top-ranked stocks that can beat earnings estimates in their next releases.
Danaher Announces Quarterly Dividends
WASHINGTON, Sept. 14, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.21 per share of its common sto...
Top 5 High-Flying Low-Beta Stocks for a Volatile September
We have narrowed down our search to five large-cap low-beta stocks that have provided double-digit returns in the past three months. These are: DHR, COST, CARR, MSI, and RSG.
Huntington's Jill Garvey on the stocks presenting opportunity amid fears of rising rates
Jill Garvey, Senior Vice President & Senior Wealth Strategist at Huntington Private Bank, joins Worldwide Exchange to discuss her market outlook.
3 Red-Hot Healthcare Stocks to Buy in September
These businesses are firing on all cylinders.
Danaher (DHR) Gains As Market Dips: What You Should Know
Danaher (DHR) closed at $332.43 in the latest trading session, marking a +0.3% move from the prior day.
SCIEX Builds on Cadence of Innovation in Biopharma With Biologics Explorer
FRAMINGHAM, Mass.--(BUSINESS WIRE)--SCIEX builds on cadence of innovation in biopharma with Biologics Explorer, enabling protein characterization analysis for the ZenoTOF 7600 system
SCIEX Presents Industry First Multi-Capillary System for CE-SDS, the BioPhase 8800 System
FRAMINGHAM, Mass.--(BUSINESS WIRE)--SCIEX presents the latest capillary electrophoresis solution, the BioPhase 8800 system, the only multi-capillary system for CE-SDS.
Danaher Completes Acquisition of Aldevron
WASHINGTON , Aug. 30, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today the completion of its acquisition of Aldevron. As previously announced, Aldevron will operate as a ...
Danaher (DHR) Stock Rise 25% in 3 Months: What's Driving It?
Danaher (DHR), with a 25% rise in shares in the past three months, benefits from strong demand, solid product offerings and synergies from buyouts. Shareholder-friendly policies add to its appeal.